Wherefore ketamine?

Current Opinion in Anaesthesiology

Volumn 23, Issue 4, 2010, Pages 455-460

  Persson, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anesthesia; ketamine; pain

Indexed keywords

CHLORBUTOL; CLONIDINE; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; INTERLEUKIN 6; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE; RECREATIONAL DRUG; TUMOR NECROSIS FACTOR ALPHA; ANESTHETIC AGENT;

ANALGESIA; ANESTHESIA INDUCTION; ANOSMIA; ANTIINFLAMMATORY ACTIVITY; APNEA; APOPTOSIS; BLADDER DYSFUNCTION; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; CHRONIC PAIN; CORONARY ARTERY BYPASS SURGERY; CYSTITIS; DELIRIUM; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; ENANTIOMER; HUMAN; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LONG TERM CARE; LOW DRUG DOSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NOCICEPTION; NONHUMAN; PATIENT CONTROLLED ANALGESIA; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SALIVATION; SIDE EFFECT; SINGLE DRUG DOSE; SURGICAL PATIENT; TREATMENT INDICATION; URINARY FREQUENCY; ANIMAL; CHEMISTRY; GENERAL ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; TOXICITY;

ADMINISTRATION, INHALATION; ANESTHESIA, GENERAL; ANESTHETICS, DISSOCIATIVE; ANIMALS; HUMANS; KETAMINE; PERIOPERATIVE CARE;

EID: 77954660031     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32833b49b3     Document Type: Review

References (74)

1. Idvall J. Ketamine-still going strong. Curr Opin Anaesthesiol 1992; 5:509-514.
2. Granry JC, Dube L, Turroques H, Conreux F. Premedication of the pediatric patient: anesthesia for the uncooperative child. Curr Opin Anaesthesiol 2000; 13:299-302.
3. Lois F, De Kock M. Something new about ketamine for pediatric anesthesia? Curr Opin Anaesthesiol 2008; 21:340-344.
4. Aroni F, Iacovidou N, Dontas I, et al. Pharmacological aspects and potential new clinical applications of ketamine: re-evaluation of an old drug. J Clin Pharmacol 2009; 49:957-964.
5. Bell RF. Ketamine for chronic noncancer pain. Pain 2009; 141:210-214.
6. Chizh BA. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol 2007; 21:259-271.
7. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain: multiple drug targets and multiple uses. Curr Pharm Des 2005; 11:2977-2994.
8. WuGJ, Chen TL, Ueng YF, et al. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 2008; 228:105-113.
9. De Kock MF, Lavand'homme PM. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol 2007; 21:85-98.
10. Machado-Vieira R, Salvadore G, Diazgranados N, et al. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009; 123:143-150.
11. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother 2006; 60:341-348.
12. Persson J. The ketamine enigma. Acta Anaesthesiol Scand 2008; 52:453-455.
13. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10:895-926.
14. Guirimand F, Dupont X, Brasseur L, et al. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesth Analg 2000; 90:408-414.
15. Carstensen M, Moller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth 2010; 104:401-406.
16. Kissin I, Bright CA, Bradley EL Jr. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamineopioid analgesic combinations? Anesth Analg 2000; 91:1483-1488.
17. Ben-David B, Chelly JE. Propofol alters ketamine effect on opiate-induced hyperalgesia. Anesth Analg 2009; 108:1353-1354; author reply 1353-1354.
18. Engelhardt T, Zaarour C, Naser B, et al. Intraoperative low-dose ketamine does not prevent a remifentanil-induced increase in morphine requirement after pediatric scoliosis surgery. Anesth Analg 2008; 107:1170-1175.
19. Sigtermans M, Noppers I, Sarton E, et al. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in complex regional pain syndrome type 1 patients. Eur J Pain 2010; 14:302-307.
20. Sigtermans M, Dahan A, Mooren R, et al. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic- pharmacodynamic modeling study in healthy volunteers. Anesthesiology 2009; 111:892-903.
21. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol 2008; 182:313-333.
22. Persson J, Hasselstrom J, Maurset A, et al. Pharmacokinetics and nonanalgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity. Eur J Clin Pharmacol 2002; 57:869-875.
23. Schuttler J. S-(+)-ketamine. The beginning of a new ketamine era? Anaesthesist 1992; 41:585-587.
24. Pfenninger EG, Durieux ME, Himmelseher S. Cognitive impairment after smalldose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers. Anesthesiology 2002; 96:357-366.
25. Mathisen LC, Skjelbred P, Skoglund LA, et al. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995; 61:215-220.
26. Restrepo JG, Garcia-Martin E, Martinez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab 2009; 10:236-246.
27. Capponi L, Schmitz A, Thormann W, et al. In-vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs. Am J Vet Res 2009; 70:777-786.
28. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005; 33:311-322.
29. Capel MM, Jenkins R, Jefferson M, et al. Use of ketamine for ischemic pain in end-stage renal failure. J Pain Symptom Manage 2008; 35:232-234.
30. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101:524-534.
31. Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth 2010; 24:131-142.
32. Yaksh TL, Tozier N, Horais KA, et al. Toxicology profile of N-methyl-Daspartate antagonists delivered by intrathecal infusion in the canine model. Anesthesiology 2008; 108:938-949.
33. Green SM, Cote CJ. Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine. Ann Emerg Med 2009; 54:181-190.
34. Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2009; 105:121-133.
35. Narendran R, Frankle WG, Keefe R, et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 2005; 162:2352-2359.
36. Congedo E, Sgreccia M, De Cosmo G. New drugs for epidural analgesia. Curr Drug Targets 2009; 10:696-706.
37. El Shobary HM, Sonbul ZM, Schricker TP. Epidural ketamine for postoperative analgesia in the elderly. Middle East J Anesthesiol 2008; 19: 1369-1378.
38. Mayell A, Natusch D. Anosmia: a potential complication of intranasal ketamine. Anaesthesia 2009; 64:457-458.
39. Bell RF, Kalso E. Is intranasal ketamine an appropriate treatment for chronic noncancer breakthrough pain? Pain 2004; 108 (1-2):1-2.
40. Tsai T-H, Cha T-L, Lin C-M, et al. Ketamine-associated bladder dysfunction. Int J Urol 2009; 16:826-829.
41. Chiew YW, Yang CS. Disabling frequent urination in a young adult: ketamineassociated ulcerative cystitis. Kidney Int 2009; 76:123-124.
42. Benitez-Rosario MA, Feria M, Salinas-Martin A, et al. A retrospective comparison of the dose ratio between subcutaneous and oral ketamine. J Pain Symptom Manage 2003; 25:400-402.
43. Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain 2009; 146 (1-2):18-25.
44. Heidari SM, Saghaei M, Hashemi SJ, et al. Effect of oral ketamine on the postoperative pain and analgesic requirement following orthopedic surgery. Acta Anaesthesiol Taiwan 2006; 44:211-215.
45. Christensen K, Rogers E, Green GA, et al. Safety and efficacy of intranasal ketamine for acute postoperative pain. Acute Pain 2007; 9:183-192.
46. Chong C, Schug SA, Page-Sharp M, et al. Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: preliminary findings from a three-way randomized, crossover study. Clin Drug Investig 2009; 29: 317-324
47. Canbay O, Celebi N, Uzun S, et al. Topical ketamine and morphine for posttonsillectomy pain. Eur J Anaesthesiol 2008; 25:287-292.
48. Lehman JS, Sciallis GF. Effective use of topical amitriptyline hydrochloride 2.5% and ketamine hydrochloride 0.5% for analgesia in refractory proctodynia. J Drugs Dermatol 2008; 7:887-889.
49. Canbay O, Celebi N, Sahin A, et al. Ketamine gargle for attenuating postoperative sore throat. Br J Anaesth 2008; 100:490-493.
50. Dal D, Celebi N, Elvan EG, et al. The efficacy of intravenous or peritonsillar infiltration of ketamine for postoperative pain relief in children following adenotonsillectomy. Paediatr Anaesth 2007; 17:263-269.
51. Viscomi CM, Friend A, Parker C, et al. Ketamine as an adjuvant in lidocaine intravenous regional anesthesia: a randomized, double-blind, systemic control trial. Reg Anesth Pain Med 2009; 34:130-133.
52. Persson J, Scheinin H, Hellstrom G, et al. Ketamine antagonises alfentanilinduced hypoventilation in healthy male volunteers. Acta Anaesthesiol Scand 1999; 43:744-752.
53. Miller, DK, editor. Anesthesia. 7th ed. Philadelphia: Churchill Livingstone; 2009.
54. Melendez E, Bachur R. Serious adverse events during procedural sedation with ketamine. Pediatr Emerg Care 2009; 25:325-328.
55. Green SM, Roback MG, Krauss B, et al. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med 2009; 54:158-168; e1-4.
56. McGlone R, Carley S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: does the time of fasting affect complication rates during ketamine sedation? Emerg Med J 2008; 25:367-369.
57. Morris C, Perris A, Klein J, et al. Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia 2009; 64:532-539.
58. Hudetz JA, Patterson KM, Iqbal Z, et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2009; 23:651-657.
59. MacPherson RD, Loo CK. Cognitive impairment following electroconvulsive therapy:does the choice of anesthetic agent make a difference? J ECT 2008; 24:52-56.
60. Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008; 82 (2-3):219-222.
61. Voss LJ, Sleigh JW, Barnard JP, et al. The howling cortex: seizures and general anesthetic drugs. Anesth Analg 2008; 107:1689-1703.
62. Blake DR.Office-based anesthesia: dispelling common myths. Aesthet Surg J 2008; 28:564-570; discussion 571-572.
63. Bell Rae F, Dahl Jørgen B, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database of Systematic Reviews, doi: 10.1002/14651858.CD004603.pub2.
64. Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004; 99:482-495.
65. Berti M, Baciarello M, Troglio R, et al. Clinical uses of low-dose ketamine in patients undergoing surgery. Curr Drug Targets 2009; 10:707-715.
66. Abu-Shahwan I. Ketamine does not reduce postoperative morphine consumption after tonsillectomy in children. Clin J Pain 2008; 24:395-398.
67. Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis 2009; 5:67-71.
68. Svenson JE, Abernathy MK. Ketamine for prehospital use: new look at an old drug. Am J Emerg Med 2007; 25:977-980.
69. Bredmose PP, Lockey DJ, Grier G, et al. Prehospital use of ketamine for analgesia and procedural sedation. Emerg Med J 2009; 26:62-64.
70. Malchow RJ, Black IH. The evolution of pain management in the critically ill trauma patient: emerging concepts from the global war on terrorism. Crit Care Med 2008; 36:S346-S357.
71. Singh R, Batra YK, Bharti N, et al. Comparison of propofol versus propofolketamine combination for sedation during spinal anesthesia in children: randomized clinical trial of efficacy and safety. Paediatr Anaesth 2010. [Epub ahead of print]
72. Legge J, Ball N, Elliott DP. The potential role of ketamine in hospice analgesia: a literature review. Consult Pharm 2006; 21:51-57.
73. Stefanczyk-Sapieha L, Oneschuk D, Demas M. Intravenous ketamine 'burst' for refractory depression in a patient with advanced cancer. J Palliat Med 2008; 11:1268-1271.
74. Mercadante S, Villari P, Ferrera P, et al. Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain 2009; 25:648-649.